Literature DB >> 8281136

Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions.

J Naylor1, A Brinke, S Hassock, P M Green, F Giannelli.   

Abstract

Surprisingly half of all severe haemophilia A patients have no mutation in the promoter, coding sequences and normal RNA processing signals of the factor VIII gene. Instead they manifest a unique mRNA defect that prevents the amplification of the message across the boundary between exon 22 and 23. This locates the defect to internal regions of intron 22. Novel sequences 3' to exon 22 were isolated from the 9 available patients with the above abnormality by combining RACE and vectorette amplifications on trace amounts of mRNA. This showed that exons 1-22 of the factor VIII mRNA had become part of a hybrid message containing new multi exonic sequences expressed in normal cells. The novel sequences were not located in a YAC covering the whole factor VIII gene. Southern blots from patients probed by novel sequences and clones covering intron 22 showed no obvious abnormalities. This suggested inversions involving intron 22 repeated sequences. Screening of 3 YAC libraries with the novel sequences located them at least 200 kb telomeric (5') to factor VIII and pulsed field gel analysis detected abnormal bands in patients. This demonstrates that the mutations in the patients are inversions of long DNA regions possibly involving the repeated sequences and occurring at the surprising rate of approximately 4 x 10(-6) per gene per gamete per generation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281136     DOI: 10.1093/hmg/2.11.1773

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

1.  Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation.

Authors:  Yuhri Miyawaki; Atsuo Suzuki; Yuhta Fujimori; Akira Takagi; Takashi Murate; Nobuaki Suzuki; Akira Katsumi; Tomoki Naoe; Koji Yamamoto; Tadashi Matsushita; Junki Takamatsu; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2010-08-11       Impact factor: 2.490

2.  High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders.

Authors:  G H Thomas
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Mutation detection in the repeated part of the PKD1 gene.

Authors:  J H Roelfsema; L Spruit; J J Saris; P Chang; Y Pirson; G J van Ommen; D J Peters; M H Breuning
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.

Authors:  Irena Hudecova; Peiyong Jiang; Joanna Davies; Y M Dennis Lo; Rezan A Kadir; Rossa W K Chiu
Journal:  Blood       Date:  2017-05-10       Impact factor: 22.113

5.  Inverse PCR to perform long-distance haplotyping: main applications to improve preimplantation genetic diagnosis in hemophilia.

Authors:  Miguel Martín Abelleyro; Vanina Daniela Marchione; Micaela Palmitelli; Claudia Pamela Radic; Daniela Neme; Irene Beatriz Larripa; Enrique Medina-Acosta; Carlos Daniel De Brasi; Liliana Carmen Rossetti
Journal:  Eur J Hum Genet       Date:  2019-01-09       Impact factor: 4.246

6.  Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families.

Authors:  P P Deutz-Terlouw; M Losekoot; R Olmer; W C Pieneman; S de Vries-v d Weerd; E Briët; E Bakker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

7.  The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion.

Authors:  Jay N Lozier; Amalia Dutra; Evgenia Pak; Nan Zhou; Zhili Zheng; Timothy C Nichols; Dwight A Bellinger; Marjorie Read; Richard A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 8.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

9.  Detection of mutations in ectopic factor VIII transcripts from nine haemophilia A patients and the correlation with phenotype.

Authors:  S I Bidichandani; W G Lanyon; C R Shiach; G D Lowe; J M Connor
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 10.  Blood coagulation factor VIII: An overview.

Authors:  G M Bhopale; R K Nanda
Journal:  J Biosci       Date:  2003-12       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.